关键词:
ADME
DMPK
disposition
distribution
partition coefficients
pharmacokinetics
tissue distribution
toxicology
volume of distribution
safety assessment
摘要:
Having an understanding of drug tissue accumulation can be informative in the assessment of target organ toxicities;however, obtaining tissue drug levels from toxicology studies by bioanalytical methods is labor-intensive and infrequently performed. Additionally, there are no described methods for predicting tissue drug distribution for the experimental conditions in toxicology studies, which typically include non-steady-state conditions and very high exposures that may saturate several processes. The aim was the development of an algorithm to provide semiquantitative and quantitative estimates of tissue-to-plasma concentration ratios (K-p) for several tissues from readily available parameters of pharmacokinetics (PK) such as volume of distribution (V-d) and clearance of each drug, without performing tissue measurement in vivo. The computational approach is specific for the oral route of administration and non-steady-state conditions and was applied for a dataset of 29 Genentech small molecules such as neutral compounds as well as weak and strong organic bases. The maximum success rate in predicting K-p values within 2.5-fold error of observed K-p values was 82% at low doses (<100 mg/kg) in preclinical species. Prediction accuracy was relatively lower with saturation at high doses (100 mg/kg);however, an approach to perform low-to-high dose extrapolations of K-p values was presented and applied successfully in most cases. An approach for the interspecies scaling was also applied successfully. Finally, the proposed algorithm was usedin a case study and successfully predicted differential tissue distribution of two small-molecule MET kinase inhibitors, which had different toxicity profiles in mice. This newly developed algorithm can be used to predict the partition coefficients K-p for small molecules in toxicology studies, which can be leveraged to optimize the PK drivers of tissue distribution in an attempt to decreasedrug tissue level,andimprove safety margins. (c)